National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

anti-TGF-beta monoclonal antibody GC1008 (AN-tee ... MAH-noh-KLOH-nul AN-tee-BAH-dee ...)

 A monoclonal antibody being studied in the treatment of kidney cancer, melanoma, and pulmonary fibrosis. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Anti-TGF-beta monoclonal antibody GC1008 binds to the protein transforming growth factor-beta (TGFß) and may block the growth of cancer cells that make it. Also called GC1008.



Previous Definitions:anti-EpCAM-Pseudomonas-exotoxin fusion protein, anti-idiotype vaccine, anti-IL-6 chimeric monoclonal antibody, anti-inflammatory, anti-mesothelin monoclonal antibody MORAb-009
Next Definitions:anti-VEGFR monoclonal antibody, antiandrogen, antiandrogen therapy, antiangiogenesis, antiangiogenic

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov